Carbidopa
Carbidopa by Zyntex is a high-purity pharmaceutical API (CAS 28860-95-9) used as a potent dopa decarboxylase inhibitor. It is essential for enhancing the efficacy of Levodopa in Parkinson’s disease treatments by preventing peripheral metabolism.
Description
Comprehensive Product Overview
In the field of neuropharmacology, the ability to prevent the peripheral breakdown of dopamine precursors is a major advantage. Carbidopa is specifically selected because it inhibits the enzyme aromatic L-amino acid decarboxylase outside the blood-brain barrier. For instance, it reduces the required dose of Levodopa, thereby minimizing systemic side effects such as nausea and cardiovascular complications. Consequently, it facilitates a higher concentration of active medication reaching the brain. As a result, Zyntex ensures that our pharmaceutical-grade Carbidopa meets the highest standards of purity for clinical safety.
Moreover, the high-purity Carbidopa provided by Zyntex is a vital component in the development of controlled-release oral formulations. This application allows for more stable plasma levels of dopamine, undoubtedly pushing the boundaries of chronic disease management. At the same time, its role in improving patient compliance through better tolerability is highly valued by global healthcare providers. In short, our product serves as a dependable “bioavailability enhancer” for companies focusing on advanced neurological treatments and specialized API synthesis.
Recently, scientific interest has surged regarding the use of Carbidopa in research involving dopaminergic pathways and experimental therapeutic models. Because of this, Zyntex offers bulk supply options that strictly adhere to international pharmacopeia standards (USP/EP/BP) to provide reliable consistency for large-scale pharmaceutical manufacturing. Ultimately, by choosing Zyntex as your supplier, you secure a reliable supply chain that balances chemical potency with rigorous regulatory compliance. To conclude, our commitment to excellence ensures that your manufacturing processes achieve the highest levels of quality and pharmaceutical integrity.
Key Industrial Applications
This high-potency pharmaceutical agent is specifically vital in the following four sectors:
🧠 Parkinson’s Therapy
Key component in Levodopa combinations; thus increasing brain dopamine levels while reducing peripheral toxicity.
💊 API Manufacturing
Used as a primary active ingredient; consequently vital for the production of generic and brand-name neuro-medications.
🧪 Clinical Research
Functions as a reference standard in neurochemical studies; undoubtedly essential for laboratory and diagnostic R&D.
🔬 Specialty Synthesis
Utilized in the synthesis of hydrazino amino acid derivatives; specifically supporting advanced medicinal chemistry.
Technical Specifications
| Parameter | Standard Value |
|---|---|
| Product Name | Carbidopa Monohydrate |
| Assay / Purity | 98.5% – 101.0% |
| Appearance | White to off-white crystalline powder |
| CAS Number | 28860-95-9 |
⚠️ Safety Warning: Carbidopa is a potent pharmacological agent and must be handled under strict laboratory conditions. Therefore, it is for industrial and research use only. Store in a cool, dry place away from direct light and moisture to maintain chemical stability.
